INSP Inspire Medical Systems Inc

Price (delayed)

$229.22

Market cap

$6.78B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.72

Enterprise value

$6.62B

Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the ...

Highlights
INSP's EPS has surged by 55% year-on-year and by 35% since the previous quarter
The gross profit has soared by 55% YoY and by 10% from the previous quarter
The company's quick ratio fell by 16% YoY and by 8% QoQ

Key stats

What are the main financial stats of INSP
Market
Shares outstanding
29.59M
Market cap
$6.78B
Enterprise value
$6.62B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
11.82
Price to sales (P/S)
10.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.6
Earnings
Revenue
$624.8M
EBIT
-$19.91M
EBITDA
-$15.66M
Free cash flow
$1.02M
Per share
EPS
-$0.72
Free cash flow per share
$0.03
Book value per share
$19.39
Revenue per share
$21.32
TBVPS
$23.1
Balance sheet
Total assets
$676.81M
Total liabilities
$104.3M
Debt
$24.85M
Equity
$572.51M
Working capital
$515.63M
Liquidity
Debt to equity
0.04
Current ratio
7.6
Quick ratio
7.05
Net debt/EBITDA
10.26
Margins
EBITDA margin
-2.5%
Gross margin
84.5%
Net margin
-3.4%
Operating margin
-6.4%
Efficiency
Return on assets
-3.4%
Return on equity
-3.9%
Return on invested capital
-9%
Return on capital employed
-3.3%
Return on sales
-3.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INSP stock price

How has the Inspire Medical Systems stock price performed over time
Intraday
-4.95%
1 week
-1.09%
1 month
12.12%
1 year
-13.04%
YTD
12.68%
QTD
6.72%

Financial performance

How have Inspire Medical Systems's revenue and profit performed over time
Revenue
$624.8M
Gross profit
$528.22M
Operating income
-$40.27M
Net income
-$21.15M
Gross margin
84.5%
Net margin
-3.4%
INSP's net margin has soared by 69% YoY and by 40% QoQ
The gross profit has soared by 55% YoY and by 10% from the previous quarter
The net income has soared by 53% YoY and by 35% from the previous quarter
Inspire Medical Systems's revenue has soared by 53% YoY and by 10% from the previous quarter

Growth

What is Inspire Medical Systems's growth rate over time

Valuation

What is Inspire Medical Systems stock price valuation
P/E
N/A
P/B
11.82
P/S
10.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.6
INSP's EPS has surged by 55% year-on-year and by 35% since the previous quarter
The P/B is 31% below the 5-year quarterly average of 17.2 and 10% below the last 4 quarters average of 13.1
The company's equity rose by 15% YoY and by 5% QoQ
The stock's P/S is 54% less than its 5-year quarterly average of 23.5 and 18% less than its last 4 quarters average of 13.1
Inspire Medical Systems's revenue has soared by 53% YoY and by 10% from the previous quarter

Efficiency

How efficient is Inspire Medical Systems business performance
INSP's ROIC has soared by 84% YoY and by 63% from the previous quarter
INSP's return on sales has surged by 69% year-on-year and by 43% since the previous quarter
INSP's ROE has soared by 69% year-on-year and by 38% since the previous quarter
INSP's ROA has soared by 68% YoY and by 38% from the previous quarter

Dividends

What is INSP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INSP.

Financial health

How did Inspire Medical Systems financials performed over time
The total liabilities has soared by 51% YoY and by 9% from the previous quarter
The company's total assets rose by 20% YoY and by 6% QoQ
INSP's debt is 96% lower than its equity
INSP's debt to equity has surged by 100% year-on-year but it is down by 20% since the previous quarter
The company's equity rose by 15% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.